Prophylactic surgery rates among men with breast cancer nearly double
the ONA take:
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011, which mirrors a trend seen in women with breast cancer, according to a report from American Cancer Society and Dana Farber Cancer Institute researchers.
In women, particularly younger women, use of CPM has increased over the past two decades despite a lack of evidence for survival benefit, associated costs, and possible complications. Breast cancer in men accounts for approximately 1% of all cases in the United States.
The researchers pulled nationwide data from the North American Association of Central Cancer Registries on 6,332 men who underwent surgery for breast cancer limited to one breast between 2004 and 2011.
Rate of CMP among men increased from 3.0% in 2004 to 5.6% in 2011. The sociodemographic factors linked to more surgery in men were similar to those for women who underwent CPM: being white, younger age, and having private insurance.
However, the study did not have data on other factors linked to women who choose to undergo CPM, such as genetic testing, family history, magnetic resonance imaging, or fear of breast cancer occurring in the other breast.
The rates of contralateral prophylactic mastectomy (CPM) among men with breast nearly doubled between 2004 and 2011.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Exercise May Mitigate Doxorubicin-related Cardiotoxicity
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
- Exercise May Mitigate Cardiotoxicity Associated With Doxorubicin Treatment
- Mobile Health Apps Becoming More Popular Among Patients and Clinicians
- Online Learning Modules Improve Exercise Counseling, But Not Participation
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|